- Home
- MPLN vs MGTX Comparison
MPLN vs MGTX Comparison
Compare MPLN & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MPLN
- MGTX
- Stock Information
- Founded
- MPLN 1980
- MGTX 2015
- Country
- MPLN United States
- MGTX United States
- Employees
- MPLN N/A
- MGTX N/A
- Industry
- MPLN Business Services
- MGTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MPLN Consumer Discretionary
- MGTX Health Care
- Exchange
- MPLN Nasdaq
- MGTX Nasdaq
- Market Cap
- MPLN 188.6M
- MGTX 411.4M
- IPO Year
- MPLN N/A
- MGTX N/A
- Fundamental
- Price
- MPLN $10.89
- MGTX $5.98
- Analyst Decision
- MPLN Hold
- MGTX Strong Buy
- Analyst Count
- MPLN 2
- MGTX 2
- Target Price
- MPLN $25.00
- MGTX $22.50
- AVG Volume (30 Days)
- MPLN 75.1K
- MGTX 325.1K
- Earning Date
- MPLN 11-05-2024
- MGTX 11-12-2024
- Dividend Yield
- MPLN N/A
- MGTX N/A
- EPS Growth
- MPLN N/A
- MGTX N/A
- EPS
- MPLN N/A
- MGTX N/A
- Revenue
- MPLN $954,923,000.00
- MGTX $8,122,000.00
- Revenue This Year
- MPLN N/A
- MGTX $133.83
- Revenue Next Year
- MPLN $0.63
- MGTX $655.34
- P/E Ratio
- MPLN N/A
- MGTX N/A
- Revenue Growth
- MPLN N/A
- MGTX 26.87
- 52 Week Low
- MPLN $6.35
- MGTX $3.49
- 52 Week High
- MPLN $69.20
- MGTX $7.60
- Technical
- Relative Strength Index (RSI)
- MPLN 55.66
- MGTX 78.17
- Support Level
- MPLN $9.90
- MGTX $3.97
- Resistance Level
- MPLN $12.40
- MGTX $6.24
- Average True Range (ATR)
- MPLN 1.06
- MGTX 0.33
- MACD
- MPLN 0.26
- MGTX 0.20
- Stochastic Oscillator
- MPLN 69.14
- MGTX 88.56
About MPLN MultiPlan Corporation
MultiPlan Corp is a provider of data analytics and technology-enabled solutions designed to bring affordability, efficiency, and fairness to the U.S. healthcare industry. The company interprets clients' needs and customizes solutions that combine its payment integrity, network-based, and analytics-based services. The Company's focus is being a value-added provider of data analytics and technology-enabled end-to-end cost management, payment and revenue integrity solutions to the U.S. healthcare industry.
About MGTX MeiraGTx Holdings plc
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.